Anti-body Drug Conjugates

Date/Time: Tuesday, July 24, 2018 - 10:00 AM to 12:00 PM


Antibody-drug conjugates are one of the fastest-growing therapeutic platform, with 4 FDA approved drugs and nearly 80 candidates in clinical trials. Current and emerging ADCs employ a range of scaffolds and chemistries to improve stability and efficacy.